AbbVie Inc.
Current price221.59USD
Fair value (est., median)337.9USD
UndervaluedFair valueOvervalued
-34.4% below fair valueWould need to rise ~52.5% to reach fair value.
Health Check
49.1
Overall / 100
Good (66+)Caution (40–65)Risk (<40)
Value84.4/100
Trades about 34.4% below its estimated fair value.
- Discount to fair value
- 34.4%
- Price to book
- —
- Fair-value confidence
- —
Future40/100
Modest growth of about 8% a year is expected.
- Forecast growth (rev.)
- 8%
- Revenue CAGR (14y)
- 9.4%
- Earnings CAGR (14y)
- —
Past80/100
A steady, profitable operating history.
- Return on equity
- —
- Net margin
- 6.9%
- Earnings CAGR (14y)
- —
- Profitable years
- 12/15
Health12.5/100
Balance sheet is manageable.
- Debt to equity
- —
- Net debt to equity
- —
- Cash covers total debt
- No
- Free cash flow
- Positive
Dividend28.6/100
Yields 2.98% but pays out more than it earns — watch sustainability.
- Dividend yield
- 2.98%
- Payout ratio
- 277.2%
- Covered by free cash flow
- Yes
- Years paying
- 13
- Dividend growth
- —
Rewards
- Trades 34.4% below estimated fair value.
Risks
- Stretched balance sheet / elevated debt.
- Dividend payout looks stretched.
Scores are computed automatically from the real financial statements (Value from fair value; the rest from growth, profitability, balance sheet and dividends). A decision aid, not investment advice.
Price, corporate actions & news
Demo series
D — DividendS — Split▲ good · ▼ bad newstap a marker for details
Growth & profitability
Revenue, net income and margin.
RevenueNet incomeNet margin %tap a bar for figures
Key figures
| Metric | FY'21 | FY'22 | FY'23 | FY'24 | FY'25 |
|---|---|---|---|---|---|
| Revenue | 56.20B | 58.05B | 54.32B | 56.33B | 61.16B |
| Net Income | 11.54B | 11.81B | 4.84B | 4.26B | 4.21B |
| Net Margin | 20.5% | 20.3% | 8.9% | 7.6% | 6.9% |
| Operating Cash Flow | 22.78B | 24.94B | 22.84B | 18.81B | 19.03B |
| OCF Margin | 40.5% | 43.0% | 42.0% | 33.4% | 31.1% |
| Capital Expenditure | 787.00M | 695.00M | 777.00M | 974.00M | 1.21B |
| Free Cash Flow | 21.99B | 24.25B | 22.06B | 17.83B | 17.82B |
| FCF Margin | 39.1% | 41.8% | 40.6% | 31.7% | 29.1% |
| FCF Conversion | 190.5% | 205.3% | 455.7% | 418.8% | 423.6% |
| EPS (Diluted) | 6.53/sh | 6.68/sh | 2.74/sh | 2.41/sh | 2.38/sh |
| Dividend / Share | 5.24/sh | 5.68/sh | 5.97/sh | 6.24/sh | 6.60/sh |
Dividend return (if you buy today)if you buy today
Dividend yield2.98%
Dividend / share6.60 USD
If you invest
USD
Shares (≈)45
Est. annual income296.90 USD
At this rate, dividends alone return your capital in ~33.6 years.
Dividend history
Dividend / share & historical yield (USD).
Dividend / share yield %tap a bar for figures
Quarterly dividends & yield
Per-share dividends by quarter, full-year total, and yield on the year's average price · USD
| Year | Q1 | Q2 | Q3 | Q4 | Full year | Yield (avg) |
|---|---|---|---|---|---|---|
| 2026 | 1.73 | 1.73 | — | — | 3.46 | 1.6% |
| 2025 | 1.64 | 1.64 | 1.64 | 1.64 | 6.60 | 3.2% |
| 2024 | 1.55 | 1.55 | 1.55 | 1.55 | 6.24 | 3.5% |
| 2023 | 1.48 | 1.48 | 1.48 | 1.48 | 5.97 | 4.0% |
| 2022 | 1.41 | 1.41 | 1.41 | 1.41 | 5.68 | 3.8% |
| 2021 | 1.30 | 1.30 | 1.30 | 1.30 | 5.24 | 4.6% |
| 2020 | 1.18 | 1.18 | 1.18 | 1.18 | 4.37 | 4.8% |
| 2019 | — | — | — | — | 3.60 | 4.6% |
| 2018 | — | — | — | — | 3.16 | 3.3% |
| 2017 | 0.64 | 0.64 | 0.64 | 0.64 | 2.32 | 3.1% |
| 2016 | 0.57 | 0.57 | 0.57 | 0.57 | 2.10 | 3.5% |
| 2015 | 0.49 | 0.51 | 0.51 | 0.51 | 1.86 | 3.0% |
| 2014 | 0.40 | 0.42 | 0.42 | 0.42 | 1.51 | 2.7% |
| 2013 | 0.40 | 0.40 | 0.40 | 0.40 | 1.45 | 3.2% |
| 2012 | — | — | — | — | — | — |
| 2011 | — | — | — | — | — | — |
Corporate actions
DCash Dividend
1.73 USD /sh2026-04-15
DCash Dividend
1.73 USD /sh2026-01-16
DCash Dividend
1.64 USD /sh2025-10-15
DCash Dividend
1.64 USD /sh2025-07-15
DCash Dividend
1.64 USD /sh2025-04-15
DCash Dividend
1.64 USD /sh2025-01-15
DCash Dividend
1.55 USD /sh2024-10-15
DCash Dividend
1.55 USD /sh2024-07-15
DCash Dividend
1.55 USD /sh2024-04-12
DCash Dividend
1.55 USD /sh2024-01-12
Valuation breakdown
Fair value = median of the applicable methods (DCF، DDM).
Discounted Cash Flow
Tap to adjust assumptions
485.17 USD
Dividend Discount Model
Tap to adjust assumptions
190.63 USD
Graham Number
Excluded — EPS ≤ 0
N/A
Residual Income (justified P/B)
Excluded — needs positive book value
N/A
Earnings Power Value
Excluded — non-positive normalized earnings
N/A
Fair Value (median)337.90 USD
▸ Show assumptions▾ Assumptions
- Effective discount rate
- 6.57%
- CAPM cost of equity
- 6.82%
- Risk-free rate
- 4.50%
- Equity risk premium
- 7.50%
- DCF growth (stage 1)
- 8.00%
- DCF terminal growth
- 3.00%
- DCF forecast years
- 10
- DDM dividend growth
- 3.00%
Tune these per company in the Hajras Odoo backend; values recompute automatically.
Wealth simulator
What if you'd invested in AbbVie Inc. regularly?
Starting year
- Invested
- 1K/yr · 14K total(2013 → today · 14 yrs)
- your value today is
- 45.6K USD
- Total return
- +225.4%(+53.0% Dividends · +172.4% Capital gain)
- Annualised (IRR)
- +18.1%
Invested14KUSD
Dividends7.4KUSD
Capital gain24.1KUSD
InvestedCapital gainDividendstap a bar for figures
Community Notes0
No notes yet. Be the first to share a thesis.